Literature DB >> 29256492

Prostate cancer: Genomic information improves risk prediction.

Diana Romero1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29256492     DOI： 10.1038/nrurol.2017.218

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Authors:  Daniel E Spratt; Jingbin Zhang; María Santiago-Jiménez; Robert T Dess; John W Davis; Robert B Den; Adam P Dicker; Christopher J Kane; Alan Pollack; Radka Stoyanova; Firas Abdollah; Ashley E Ross; Adam Cole; Edward Uchio; Josh M Randall; Hao Nguyen; Shuang G Zhao; Rohit Mehra; Andrew G Glass; Lucia L C Lam; Jijumon Chelliserry; Marguerite du Plessis; Voleak Choeurng; Maria Aranes; Tyler Kolisnik; Jennifer Margrave; Jason Alter; Jennifer Jordan; Christine Buerki; Kasra Yousefi; Zaid Haddad; Elai Davicioni; Edouard J Trabulsi; Stacy Loeb; Ashutosh Tewari; Peter R Carroll; Sheila Weinmann; Edward M Schaeffer; Eric A Klein; R Jeffrey Karnes; Felix Y Feng; Paul L Nguyen
Journal:  J Clin Oncol       Date:  2017-11-29       Impact factor: 44.544
  1 in total
  1 in total

1.  Expression of Androgen Receptor Variant 7 (AR-V7) in Circulated Tumor Cells and Correlation with Drug Resistance of Prostate Cancer Cells.

Authors:  Shuaibin Wang; Sen Yang; Cunjin Nan; Yijun Wang; Youhua He; Haiqi Mu
Journal:  Med Sci Monit       Date:  2018-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.